Changes
On 28 June 2023 at 7:30:49 am UTC, ckan_admin:
-
No fields were updated. See the metadata diff for more details.
f | 1 | { | f | 1 | { |
2 | "author": "", | 2 | "author": "", | ||
3 | "author_email": "", | 3 | "author_email": "", | ||
4 | "creator_user_id": "ad823657-25d6-44fa-84f9-59872bdc984c", | 4 | "creator_user_id": "ad823657-25d6-44fa-84f9-59872bdc984c", | ||
5 | "extras": [ | 5 | "extras": [ | ||
6 | { | 6 | { | ||
7 | "key": "ADP ID", | 7 | "key": "ADP ID", | ||
8 | "value": | 8 | "value": | ||
9 | "datasource-TUA_PHIDU-UoM_AURIN_DB_1:phidu_screening_lga_2015_17" | 9 | "datasource-TUA_PHIDU-UoM_AURIN_DB_1:phidu_screening_lga_2015_17" | ||
10 | }, | 10 | }, | ||
11 | { | 11 | { | ||
12 | "key": "Access Level", | 12 | "key": "Access Level", | ||
13 | "value": "Open Access" | 13 | "value": "Open Access" | ||
14 | }, | 14 | }, | ||
15 | { | 15 | { | ||
16 | "key": "Aggregation Level", | 16 | "key": "Aggregation Level", | ||
17 | "value": "lga2016" | 17 | "value": "lga2016" | ||
18 | }, | 18 | }, | ||
19 | { | 19 | { | ||
20 | "key": "Attribute List", | 20 | "key": "Attribute List", | ||
21 | "value": ", Breast Screening Outcomes: Cancer, Females Aged 50 | 21 | "value": ", Breast Screening Outcomes: Cancer, Females Aged 50 | ||
22 | To 69 Years 2015 And 2016 (Nsw, And Sa) 2016 And 2017 (Vic) Asr Per | 22 | To 69 Years 2015 And 2016 (Nsw, And Sa) 2016 And 2017 (Vic) Asr Per | ||
23 | 10,000 (Based On Women Screened Over A 24 Month Period), Breast | 23 | 10,000 (Based On Women Screened Over A 24 Month Period), Breast | ||
24 | Screening Outcomes: Cancer, Females Aged 50 To 69 Years 2015 And 2016 | 24 | Screening Outcomes: Cancer, Females Aged 50 To 69 Years 2015 And 2016 | ||
25 | (Nsw, And Sa) 2016 And 2017 (Vic) Number (Women Diagnosed With Breast | 25 | (Nsw, And Sa) 2016 And 2017 (Vic) Number (Women Diagnosed With Breast | ||
26 | Cancer Over A 24 Month Period), Breast Screening Outcomes: Cancer, | 26 | Cancer Over A 24 Month Period), Breast Screening Outcomes: Cancer, | ||
27 | Females Aged 50 To 69 Years 2015 And 2016 (Nsw, And Sa) 2016 And 2017 | 27 | Females Aged 50 To 69 Years 2015 And 2016 (Nsw, And Sa) 2016 And 2017 | ||
28 | (Vic) Sig., Breast Screening Participation, Females Aged 50 To 69 | 28 | (Vic) Sig., Breast Screening Participation, Females Aged 50 To 69 | ||
29 | Years 2015 And 2016 (Nsw, And Sa) 2016 And 2017 (Vic) Number (Women | 29 | Years 2015 And 2016 (Nsw, And Sa) 2016 And 2017 (Vic) Number (Women | ||
30 | Attending Over A 24 Month Period), Breast Screening Participation, | 30 | Attending Over A 24 Month Period), Breast Screening Participation, | ||
31 | Females Aged 50 To 69 Years 2015 And 2016 (Nsw, And Sa) 2016 And 2017 | 31 | Females Aged 50 To 69 Years 2015 And 2016 (Nsw, And Sa) 2016 And 2017 | ||
32 | (Vic) Per Cent, Breast Screening Participation, Females Aged 50 To 69 | 32 | (Vic) Per Cent, Breast Screening Participation, Females Aged 50 To 69 | ||
33 | Years 2015 And 2016 (Nsw, And Sa) 2016 And 2017 (Vic) Women Aged 50 To | 33 | Years 2015 And 2016 (Nsw, And Sa) 2016 And 2017 (Vic) Women Aged 50 To | ||
34 | 69 Years (Based On Average Of Two Years' Populations), Cervical | 34 | 69 Years (Based On Average Of Two Years' Populations), Cervical | ||
35 | Screening Outcomes: High Grade Abnormality, Females Aged 20 To 69 | 35 | Screening Outcomes: High Grade Abnormality, Females Aged 20 To 69 | ||
36 | Years* 2015 And 2016 (Nsw, Vic, Sa & Wa) Asr Per 1,000 (Based On Women | 36 | Years* 2015 And 2016 (Nsw, Vic, Sa & Wa) Asr Per 1,000 (Based On Women | ||
37 | Screened Over A 24 Month Period), Cervical Screening Outcomes: High | 37 | Screened Over A 24 Month Period), Cervical Screening Outcomes: High | ||
38 | Grade Abnormality, Females Aged 20 To 69 Years* 2015 And 2016 (Nsw, | 38 | Grade Abnormality, Females Aged 20 To 69 Years* 2015 And 2016 (Nsw, | ||
39 | Vic, Sa & Wa) Number (Women With A High Grade Abnormality Over A 24 | 39 | Vic, Sa & Wa) Number (Women With A High Grade Abnormality Over A 24 | ||
40 | Month Period), Cervical Screening Outcomes: High Grade Abnormality, | 40 | Month Period), Cervical Screening Outcomes: High Grade Abnormality, | ||
41 | Females Aged 20 To 69 Years* 2015 And 2016 (Nsw, Vic, Sa & Wa) Sig., | 41 | Females Aged 20 To 69 Years* 2015 And 2016 (Nsw, Vic, Sa & Wa) Sig., | ||
42 | Cervical Screening Outcomes: Low Grade Abnormality, Females Aged 20 | 42 | Cervical Screening Outcomes: Low Grade Abnormality, Females Aged 20 | ||
43 | To 69 Years* 2015 And 2016 (Nsw, Vic, Sa & Wa) Asr Per 1,000 (Based On | 43 | To 69 Years* 2015 And 2016 (Nsw, Vic, Sa & Wa) Asr Per 1,000 (Based On | ||
44 | Women Screened Over A 24 Month Period), Cervical Screening Outcomes: | 44 | Women Screened Over A 24 Month Period), Cervical Screening Outcomes: | ||
45 | Low Grade Abnormality, Females Aged 20 To 69 Years* 2015 And 2016 | 45 | Low Grade Abnormality, Females Aged 20 To 69 Years* 2015 And 2016 | ||
46 | (Nsw, Vic, Sa & Wa) Number (Women With A Low Grade Abnormality Over A | 46 | (Nsw, Vic, Sa & Wa) Number (Women With A Low Grade Abnormality Over A | ||
47 | 24 Month Period), Cervical Screening Outcomes: Low Grade Abnormality, | 47 | 24 Month Period), Cervical Screening Outcomes: Low Grade Abnormality, | ||
48 | Females Aged 20 To 69 Years* 2015 And 2016 (Nsw, Vic, Sa & Wa) Sig., | 48 | Females Aged 20 To 69 Years* 2015 And 2016 (Nsw, Vic, Sa & Wa) Sig., | ||
49 | Cervical Screening Participation, Females Aged 20 To 69 Years* 2015 | 49 | Cervical Screening Participation, Females Aged 20 To 69 Years* 2015 | ||
50 | And 2016 (Nsw, Vic, Sa & Wa) Number (Women Attending Over A 24 Month | 50 | And 2016 (Nsw, Vic, Sa & Wa) Number (Women Attending Over A 24 Month | ||
51 | Period), Cervical Screening Participation, Females Aged 20 To 69 | 51 | Period), Cervical Screening Participation, Females Aged 20 To 69 | ||
52 | Years* 2015 And 2016 (Nsw, Vic, Sa & Wa) Per Cent, Cervical Screening | 52 | Years* 2015 And 2016 (Nsw, Vic, Sa & Wa) Per Cent, Cervical Screening | ||
53 | Participation, Females Aged 20 To 69 Years* 2015 And 2016 (Nsw, Vic, | 53 | Participation, Females Aged 20 To 69 Years* 2015 And 2016 (Nsw, Vic, | ||
54 | Sa & Wa) Women Aged 20 To 69 Years (Based On Average Of Two Years' | 54 | Sa & Wa) Women Aged 20 To 69 Years (Based On Average Of Two Years' | ||
55 | Populations), LGA Code 2016, LGA Name 2016, Link To Notes On The Data | 55 | Populations), LGA Code 2016, LGA Name 2016, Link To Notes On The Data | ||
56 | Link To Australian And State/ Territory Totals Quality Indicator*, | 56 | Link To Australian And State/ Territory Totals Quality Indicator*, | ||
57 | Nbcsp: Positive Screening Result, Females 2016 And 2017 Number Of | 57 | Nbcsp: Positive Screening Result, Females 2016 And 2017 Number Of | ||
58 | Females Who Had A Positive Fobt Test Result, Nbcsp: Positive Screening | 58 | Females Who Had A Positive Fobt Test Result, Nbcsp: Positive Screening | ||
59 | Result, Females 2016 And 2017 Per Cent, Nbcsp: Positive Screening | 59 | Result, Females 2016 And 2017 Per Cent, Nbcsp: Positive Screening | ||
60 | Result, Females 2016 And 2017 Total 'Valid' Returned Results - | 60 | Result, Females 2016 And 2017 Total 'Valid' Returned Results - | ||
61 | Females, Nbcsp: Positive Screening Result, Males 2016 And 2017 Number | 61 | Females, Nbcsp: Positive Screening Result, Males 2016 And 2017 Number | ||
62 | Of Males Who Had A Positive Fobt Test Result, Nbcsp: Positive | 62 | Of Males Who Had A Positive Fobt Test Result, Nbcsp: Positive | ||
63 | Screening Result, Males 2016 And 2017 Per Cent, Nbcsp: Positive | 63 | Screening Result, Males 2016 And 2017 Per Cent, Nbcsp: Positive | ||
64 | Screening Result, Males 2016 And 2017 Total 'Valid' Returned Results - | 64 | Screening Result, Males 2016 And 2017 Total 'Valid' Returned Results - | ||
65 | Males, Nbcsp: Positive Screening Result, Persons 2016 And 2017 Number | 65 | Males, Nbcsp: Positive Screening Result, Persons 2016 And 2017 Number | ||
66 | Of Persons Who Had A Positive Fobt Test Result, Nbcsp: Positive | 66 | Of Persons Who Had A Positive Fobt Test Result, Nbcsp: Positive | ||
67 | Screening Result, Persons 2016 And 2017 Per Cent, Nbcsp: Positive | 67 | Screening Result, Persons 2016 And 2017 Per Cent, Nbcsp: Positive | ||
68 | Screening Result, Persons 2016 And 2017 Total 'Valid' Returned Results | 68 | Screening Result, Persons 2016 And 2017 Total 'Valid' Returned Results | ||
69 | - Persons, Participation In The Nbcsp, Females 2016 And 2017 Number Of | 69 | - Persons, Participation In The Nbcsp, Females 2016 And 2017 Number Of | ||
70 | Females Who Participated, Participation In The Nbcsp, Females 2016 And | 70 | Females Who Participated, Participation In The Nbcsp, Females 2016 And | ||
71 | 2017 Per Cent, Participation In The Nbcsp, Females 2016 And 2017 Total | 71 | 2017 Per Cent, Participation In The Nbcsp, Females 2016 And 2017 Total | ||
72 | Females Who Were Invited To Participate, Participation In The Nbcsp, | 72 | Females Who Were Invited To Participate, Participation In The Nbcsp, | ||
73 | Males 2016 And 2017 Number Of Males Who Participated, Participation In | 73 | Males 2016 And 2017 Number Of Males Who Participated, Participation In | ||
74 | The Nbcsp, Males 2016 And 2017 Per Cent, Participation In The Nbcsp, | 74 | The Nbcsp, Males 2016 And 2017 Per Cent, Participation In The Nbcsp, | ||
75 | Males 2016 And 2017 Total Males Who Were Invited To Participate, | 75 | Males 2016 And 2017 Total Males Who Were Invited To Participate, | ||
76 | Participation In The Nbcsp, Persons 2016 And 2017 Number Of Persons | 76 | Participation In The Nbcsp, Persons 2016 And 2017 Number Of Persons | ||
77 | Who Participated, Participation In The Nbcsp, Persons 2016 And 2017 | 77 | Who Participated, Participation In The Nbcsp, Persons 2016 And 2017 | ||
78 | Per Cent, Participation In The Nbcsp, Persons 2016 And 2017 Total | 78 | Per Cent, Participation In The Nbcsp, Persons 2016 And 2017 Total | ||
79 | Persons Who Were Invited To Participate" | 79 | Persons Who Were Invited To Participate" | ||
80 | }, | 80 | }, | ||
81 | { | 81 | { | ||
82 | "key": "Attribution", | 82 | "key": "Attribution", | ||
83 | "value": "Torrens University Australia - Public Health | 83 | "value": "Torrens University Australia - Public Health | ||
84 | Information Development Unit, (2021): PHIDU - Screening (LGA) | 84 | Information Development Unit, (2021): PHIDU - Screening (LGA) | ||
85 | 2015-2017; accessed from AURIN on [date of access]." | 85 | 2015-2017; accessed from AURIN on [date of access]." | ||
86 | }, | 86 | }, | ||
87 | { | 87 | { | ||
88 | "key": "Coordinate Ref. System", | 88 | "key": "Coordinate Ref. System", | ||
89 | "value": "EPSG:4283 (GDA_1994)" | 89 | "value": "EPSG:4283 (GDA_1994)" | ||
90 | }, | 90 | }, | ||
91 | { | 91 | { | ||
92 | "key": "Copyright Notice", | 92 | "key": "Copyright Notice", | ||
93 | "value": "\u00a9 Torrens University Australia - Public Health | 93 | "value": "\u00a9 Torrens University Australia - Public Health | ||
94 | Information Development Unit 2021" | 94 | Information Development Unit 2021" | ||
95 | }, | 95 | }, | ||
96 | { | 96 | { | ||
97 | "key": "Geometry Field", | 97 | "key": "Geometry Field", | ||
98 | "value": "geom" | 98 | "value": "geom" | ||
99 | }, | 99 | }, | ||
100 | { | 100 | { | ||
101 | "key": "Key", | 101 | "key": "Key", | ||
102 | "value": "lga_code" | 102 | "value": "lga_code" | ||
103 | }, | 103 | }, | ||
104 | { | 104 | { | ||
105 | "key": "Type", | 105 | "key": "Type", | ||
106 | "value": "dataset" | 106 | "value": "dataset" | ||
107 | }, | 107 | }, | ||
108 | { | 108 | { | ||
109 | "key": "spatial", | 109 | "key": "spatial", | ||
110 | "value": "{\"type\": \"Polygon\", \"coordinates\": [[[96.81, | 110 | "value": "{\"type\": \"Polygon\", \"coordinates\": [[[96.81, | ||
111 | -43.75], [159.11, -43.75], [159.11, -9.14], [96.81, -9.14], [96.81, | 111 | -43.75], [159.11, -43.75], [159.11, -9.14], [96.81, -9.14], [96.81, | ||
112 | -43.75]]]}" | 112 | -43.75]]]}" | ||
113 | } | 113 | } | ||
114 | ], | 114 | ], | ||
n | 115 | "groups": [], | n | 115 | "groups": [ |
116 | { | ||||
117 | "description": "Data licenced under various Open Data licences. | ||||
118 | Please check the licence for each dataset individually. To gain access | ||||
119 | head to the [ADP Access Dashboard](https://adp-access.aurin.org.au/) | ||||
120 | and accept the ADP Terms of Use.", | ||||
121 | "display_name": "Open Access", | ||||
122 | "id": "dbc8a185-ce67-449c-850e-afa744887450", | ||||
123 | "image_display_url": | ||||
124 | "https://resources.aurin.org.au/icons/unlocked_orange.png", | ||||
125 | "name": "open", | ||||
126 | "title": "Open Access" | ||||
127 | } | ||||
128 | ], | ||||
116 | "id": "a35a382c-f19b-4d3a-b8ff-ad01f4b3ab9b", | 129 | "id": "a35a382c-f19b-4d3a-b8ff-ad01f4b3ab9b", | ||
117 | "isopen": true, | 130 | "isopen": true, | ||
118 | "license_id": "CC-BY-NC-SA-3.0-AU", | 131 | "license_id": "CC-BY-NC-SA-3.0-AU", | ||
119 | "license_title": "Creative Commons | 132 | "license_title": "Creative Commons | ||
120 | Attribution-NonCommercial-ShareAlike 3.0 Australia (CC BY-NC-SA 3.0 | 133 | Attribution-NonCommercial-ShareAlike 3.0 Australia (CC BY-NC-SA 3.0 | ||
121 | AU)", | 134 | AU)", | ||
122 | "license_url": | 135 | "license_url": | ||
123 | "https://creativecommons.org/licenses/by-nc-sa/3.0/au/", | 136 | "https://creativecommons.org/licenses/by-nc-sa/3.0/au/", | ||
124 | "maintainer": null, | 137 | "maintainer": null, | ||
125 | "maintainer_email": null, | 138 | "maintainer_email": null, | ||
126 | "metadata_created": "2023-06-28T07:30:49.039600", | 139 | "metadata_created": "2023-06-28T07:30:49.039600", | ||
t | 127 | "metadata_modified": "2023-06-28T07:30:49.271505", | t | 140 | "metadata_modified": "2023-06-28T07:30:49.512093", |
128 | "name": "tua-phidu-phidu-screening-lga-2015-17-lga2016", | 141 | "name": "tua-phidu-phidu-screening-lga-2015-17-lga2016", | ||
129 | "notes": "This dataset, released August 2020, contains screening | 142 | "notes": "This dataset, released August 2020, contains screening | ||
130 | program information relating to Bowel screening, 2016 and 2017; Breast | 143 | program information relating to Bowel screening, 2016 and 2017; Breast | ||
131 | screening, 2015 and 2016 (NSW, & SA) and 2016 and 2017 (Vic); and | 144 | screening, 2015 and 2016 (NSW, & SA) and 2016 and 2017 (Vic); and | ||
132 | Cervical screening, 2015 and 2016. \n\nThe data is by Local Government | 145 | Cervical screening, 2015 and 2016. \n\nThe data is by Local Government | ||
133 | Area (LGA) 2016 geographic boundaries.\n\nFor more information please | 146 | Area (LGA) 2016 geographic boundaries.\n\nFor more information please | ||
134 | see the [data source | 147 | see the [data source | ||
135 | rrens.edu.au/current/data/sha-aust/notes/phidu_data_sources_notes.pdf) | 148 | rrens.edu.au/current/data/sha-aust/notes/phidu_data_sources_notes.pdf) | ||
136 | on the data. \n\nSource: Compiled by PHIDU based on data provided by | 149 | on the data. \n\nSource: Compiled by PHIDU based on data provided by | ||
137 | the Department of Health from the National Bowel Cancer Screening | 150 | the Department of Health from the National Bowel Cancer Screening | ||
138 | Program, 2016 and 2017;Compiled by PHIDU based on data from: 1) | 151 | Program, 2016 and 2017;Compiled by PHIDU based on data from: 1) | ||
139 | BreastScreen NSW, BreastScreen SA, and BreastScreen Vic2) average of | 152 | BreastScreen NSW, BreastScreen SA, and BreastScreen Vic2) average of | ||
140 | the ABS Estimated Resident Population, 30 June 2015 and 30 June 2016 | 153 | the ABS Estimated Resident Population, 30 June 2015 and 30 June 2016 | ||
141 | (NSW, & SA), 30 June 2016 and 30 June 2017 (Vic); Compiled by PHIDU | 154 | (NSW, & SA), 30 June 2016 and 30 June 2017 (Vic); Compiled by PHIDU | ||
142 | based on data from BreastScreen NSW, BreastScreen SA, and BreastScreen | 155 | based on data from BreastScreen NSW, BreastScreen SA, and BreastScreen | ||
143 | Vic.; Compiled by PHIDU based on data from the NSW Department of | 156 | Vic.; Compiled by PHIDU based on data from the NSW Department of | ||
144 | Health and NSW Central Cancer Registry, 2015 and 2016; Victorian | 157 | Health and NSW Central Cancer Registry, 2015 and 2016; Victorian | ||
145 | Cervical Cytology Register, 2015 and 2016; SA Cervix Screening | 158 | Cervical Cytology Register, 2015 and 2016; SA Cervix Screening | ||
146 | Program, 2015 and 2016 and Western Australia Cervical Cytology | 159 | Program, 2015 and 2016 and Western Australia Cervical Cytology | ||
147 | Register, 2015 and 2016. \n\n AURIN has spatially enabled the | 160 | Register, 2015 and 2016. \n\n AURIN has spatially enabled the | ||
148 | [original | 161 | [original | ||
149 | lases/data#social-health-atlases-of-australia-local-government-areas). | 162 | lases/data#social-health-atlases-of-australia-local-government-areas). | ||
150 | Data that was not shown/not applicable/not published/not available for | 163 | Data that was not shown/not applicable/not published/not available for | ||
151 | the specific area ('#', '..', '^', 'np, 'n.a.', 'n.y.a.' in original | 164 | the specific area ('#', '..', '^', 'np, 'n.a.', 'n.y.a.' in original | ||
152 | PHIDU data) was removed.It has been replaced by by Blank cells. For | 165 | PHIDU data) was removed.It has been replaced by by Blank cells. For | ||
153 | other keys and abbreviations refer to [PHIDU | 166 | other keys and abbreviations refer to [PHIDU | ||
154 | Keys](https://cloudstor.aarnet.edu.au/plus/s/1ryaKpnBQB6cMCp).", | 167 | Keys](https://cloudstor.aarnet.edu.au/plus/s/1ryaKpnBQB6cMCp).", | ||
155 | "num_resources": 1, | 168 | "num_resources": 1, | ||
156 | "num_tags": 2, | 169 | "num_tags": 2, | ||
157 | "organization": { | 170 | "organization": { | ||
158 | "approval_status": "approved", | 171 | "approval_status": "approved", | ||
159 | "created": "2023-06-28T06:14:34.290612", | 172 | "created": "2023-06-28T06:14:34.290612", | ||
160 | "description": "", | 173 | "description": "", | ||
161 | "id": "6af2fd4d-8220-4ab1-9b53-b5932f04915b", | 174 | "id": "6af2fd4d-8220-4ab1-9b53-b5932f04915b", | ||
162 | "image_url": | 175 | "image_url": | ||
163 | "https://resources.aurin.org.au/ckan/logos/tua_phidu.png", | 176 | "https://resources.aurin.org.au/ckan/logos/tua_phidu.png", | ||
164 | "is_organization": true, | 177 | "is_organization": true, | ||
165 | "name": "tua_phidu", | 178 | "name": "tua_phidu", | ||
166 | "state": "active", | 179 | "state": "active", | ||
167 | "title": "Torrens University Australia - Public Health Information | 180 | "title": "Torrens University Australia - Public Health Information | ||
168 | Development Unit", | 181 | Development Unit", | ||
169 | "type": "organization" | 182 | "type": "organization" | ||
170 | }, | 183 | }, | ||
171 | "owner_org": "6af2fd4d-8220-4ab1-9b53-b5932f04915b", | 184 | "owner_org": "6af2fd4d-8220-4ab1-9b53-b5932f04915b", | ||
172 | "private": false, | 185 | "private": false, | ||
173 | "relationships_as_object": [], | 186 | "relationships_as_object": [], | ||
174 | "relationships_as_subject": [], | 187 | "relationships_as_subject": [], | ||
175 | "resources": [ | 188 | "resources": [ | ||
176 | { | 189 | { | ||
177 | "cache_last_updated": null, | 190 | "cache_last_updated": null, | ||
178 | "cache_url": null, | 191 | "cache_url": null, | ||
179 | "created": "2023-06-28T07:30:49.286015", | 192 | "created": "2023-06-28T07:30:49.286015", | ||
180 | "description": "Download this dataset via the AURIN Download | 193 | "description": "Download this dataset via the AURIN Download | ||
181 | Manager", | 194 | Manager", | ||
182 | "format": "HTML", | 195 | "format": "HTML", | ||
183 | "hash": "", | 196 | "hash": "", | ||
184 | "id": "210aa390-22f7-4e8c-bab8-72c6fba21f86", | 197 | "id": "210aa390-22f7-4e8c-bab8-72c6fba21f86", | ||
185 | "last_modified": null, | 198 | "last_modified": null, | ||
186 | "metadata_modified": "2023-06-28T07:30:49.278420", | 199 | "metadata_modified": "2023-06-28T07:30:49.278420", | ||
187 | "mimetype": null, | 200 | "mimetype": null, | ||
188 | "mimetype_inner": null, | 201 | "mimetype_inner": null, | ||
189 | "name": "AURIN Download Manager", | 202 | "name": "AURIN Download Manager", | ||
190 | "package_id": "a35a382c-f19b-4d3a-b8ff-ad01f4b3ab9b", | 203 | "package_id": "a35a382c-f19b-4d3a-b8ff-ad01f4b3ab9b", | ||
191 | "position": 0, | 204 | "position": 0, | ||
192 | "resource_type": null, | 205 | "resource_type": null, | ||
193 | "size": null, | 206 | "size": null, | ||
194 | "state": "active", | 207 | "state": "active", | ||
195 | "url": | 208 | "url": | ||
196 | s.aurin.org.au/dataset/tua-phidu-phidu-screening-lga-2015-17-lga2016", | 209 | s.aurin.org.au/dataset/tua-phidu-phidu-screening-lga-2015-17-lga2016", | ||
197 | "url_type": null | 210 | "url_type": null | ||
198 | } | 211 | } | ||
199 | ], | 212 | ], | ||
200 | "state": "active", | 213 | "state": "active", | ||
201 | "tags": [ | 214 | "tags": [ | ||
202 | { | 215 | { | ||
203 | "display_name": "HEALTH SCIENCES", | 216 | "display_name": "HEALTH SCIENCES", | ||
204 | "id": "eb3abd88-b95a-475a-9e1f-4a61d7b625fe", | 217 | "id": "eb3abd88-b95a-475a-9e1f-4a61d7b625fe", | ||
205 | "name": "HEALTH SCIENCES", | 218 | "name": "HEALTH SCIENCES", | ||
206 | "state": "active", | 219 | "state": "active", | ||
207 | "vocabulary_id": null | 220 | "vocabulary_id": null | ||
208 | }, | 221 | }, | ||
209 | { | 222 | { | ||
210 | "display_name": "Public health", | 223 | "display_name": "Public health", | ||
211 | "id": "d3679db4-8fcf-43f0-915d-823ee65d4e55", | 224 | "id": "d3679db4-8fcf-43f0-915d-823ee65d4e55", | ||
212 | "name": "Public health", | 225 | "name": "Public health", | ||
213 | "state": "active", | 226 | "state": "active", | ||
214 | "vocabulary_id": null | 227 | "vocabulary_id": null | ||
215 | } | 228 | } | ||
216 | ], | 229 | ], | ||
217 | "title": "PHIDU - Screening (LGA) 2015-2017", | 230 | "title": "PHIDU - Screening (LGA) 2015-2017", | ||
218 | "type": "dataset", | 231 | "type": "dataset", | ||
219 | "url": "https://adp.aurin.org.au/geoserver/wfs", | 232 | "url": "https://adp.aurin.org.au/geoserver/wfs", | ||
220 | "version": null | 233 | "version": null | ||
221 | } | 234 | } |